Yahoo Web Search

  1. Ads
    related to MERCK & CO., INC
  1. Merck & Co., Inc. (NYSE:MRK) Has Attractive Fundamentals

    Simply Wall St. via Yahoo FinanceMay 31 17:13 PM

    Help shape the future of investing tools and you could win a $250 gift card! As an investor, I look for investments which does not compromise one fundamental factor for another. By this I mean ...

  2. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MRK.

  3. Is Merck & Co., Inc. (MRK) A Good Stock To Buy ?

    Insider Monkey via Yahoo FinanceJun 06 20:40 PM

    "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Nevertheless, we were still able to identify in advance a ...

  4. Merck's Antibiotic Zerbaxa Gets FDA Nod for New Indication

    Zacks via Yahoo FinanceJun 04 14:18 PM

    Merck & Co., Inc. MRK gained FDA approval for a supplemental new drug application looking for label expansion of its antibacterial medicine, Zerbaxa for two types of pneumonia ...

  5. Merck & Co., Inc. MRK shares have performed well this year so far. Merck’s shares have risen 6.2% this year so far compared with the industry’s increase of 0.7%.

  6. Merck's Keytruda Improves 5-Year Survival in Lung Cancer

    Zacks via Yahoo FinanceJun 03 13:39 PM

    Merck & Co., Inc. MRK presented encouraging five-year survival data on its PD-L1 inhibitor, Keytruda in patients with advanced non-small cell lung cancer (NSCLC) at the ...

  7. Merck wins U.S. FDA approval for expanded use of antibiotic

    Reuters via Yahoo FinanceJun 03 19:41 PM

    The approval is based on the treatment's late-stage trial results, which showed that Merck's drug, Zerbaxa, was as effective as another antibacterial drug. Hospital-acquired pneumonia ...

  8. Small-Cap Biotechs Aim to Steal Spotlight at Cancer Meeting

    Bloomberg via Yahoo FinanceMay 31 15:21 PM

    Companies like Iovance Biotherapeutics Inc., MacroGenics Inc. and Nektar Therapeutics will be in the spotlight when the annual event kicks off Friday in Chicago. “Sentiment heading ...

  9. PDUFA dates are deadlines for the FDA to review new drugs. The FDA is normally given 10 months to review new drugs. If a drug is selected for priority review, the FDA is allotted six months to review the drug.

  10. The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace

    Benzinga via Yahoo FinanceJun 01 15:37 PM

    Biotech stocks came under pressure this week ahead of the ASCO 2019 presentations. Headlines on legal woes related to the opioid crisis and drug price manipulation led to weakness in some stocks ...

  1. Ads
    related to MERCK & CO., INC